Neuraxis Inc (NRXS) Stock Price, Quote & News

Company Profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 812 689 0791

Website: neuraxis.com

Address:

11611 North Meridian St, Suite 330, Carmel, United States

Finnish_boy Jun. 30 at 8:59 PM

$NRXS Someone wanted to double position size when there was chance to lock in lower levels.

1 · Reply

R33dh Jun. 30 at 6:20 PM

$NRXS it's a buy for me

0 · Reply

Finnish_boy Jun. 26 at 5:17 PM

$NRXS Commerical coverage win will happen likely August-October. I read more stuff today. So my earlier post June-July was misleading. But you never know. Q2 earnings report next catalyst in August.

1 · Reply

Finnish_boy Jun. 25 at 1:00 PM

$NRXS MVC will also post public Q2 recap on 1st July. NRXS his second biggest position (orange) after NBIS.. call it top high conviction stock.. NBIS gang will roll the profits into NRXS next.. MVC and his followers start to pump stock to $15 after coverage win !! lets see

1 · Reply

Finnish_boy Jun. 25 at 12:57 PM

$NRXS Major commercial coverage win very likely in July or August.

0 · Reply

Finnish_boy Jun. 25 at 8:13 AM

$NRXS MicroCapClub and Mr. Cunha stopped posting stuff -> share price taking a deep breath. But now, share price under $7 and during next month a big commercial insurance coverage win is quite possible!! I think Q2 numbers are not epic but people underestimate growth potential in the next 1-2 years! Stock will double in a year.

0 · Reply

Finnish_boy Jun. 9 at 4:11 PM

$NRXS Added $6.5, next buy $5.75-$6.25

0 · Reply

Finnish_boy Jun. 9 at 1:55 PM

$NRXS If stock drops to 5s, it wont be there long time bc that triggers multiple substack articles and twitter posts.

1 · Reply

Finnish_boy Jun. 9 at 1:21 PM

$NRXS Does someone know when they announce the coverage? According history H2 June- July is very active time to announce new policy changes. Coverage can kick in right away or e.g start of August/September.

1 · Reply

CBAZZ03 Jun. 6 at 3:33 PM

$NRXS Hey everyone, just realized that there is a community here for NeurAxis. Done A TON of research on this company, can confidently say i’m a VERY bullish on this company, absolutely 0 reason to NOT buy this stock, going to easily 2x by EOY!

3 · Reply

NeurAxis Transcript: Lytham Partners Spring 2026 Investor Conference

May 27, 2026, 7:00 AM EDT - 5 weeks ago

NeurAxis Slides: Investor presentation

May 12, 2026, 9:00 AM EDT - 7 weeks ago

NeurAxis Earnings Call Transcript: Q1 2026

May 12, 2026, 9:00 AM EDT - 7 weeks ago

NeurAxis Quarterly report: Q1 2026

May 12, 2026, 9:00 AM EDT - 7 weeks ago

NeurAxis Earnings release: Q1 2026

May 12, 2026, 7:05 AM EDT - 7 weeks ago

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

May 5, 2026, 7:00 AM EDT - 2 months ago

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

Apr 28, 2026, 8:00 AM EDT - 2 months ago

NeurAxis Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

NeurAxis Proxy statement: Proxy filing

Apr 22, 2026, 7:00 AM EDT - 2 months ago

NeurAxis Expands Payer Coverage with Four New Medical Policies

Apr 10, 2026, 7:00 AM EDT - 3 months ago

NeurAxis, Inc. Announces Preferred Stock Dividend

2026-03-20T12:56:08.000Z - 3 months ago

Neuraxis price target raised to $13 from $8 at Craig-Hallum

Mar 19, 2026, 9:00 AM EDT - 3 months ago

NeurAxis Earnings Call Transcript: Q4 2025

Mar 19, 2026, 9:00 AM EDT - 3 months ago

NeurAxis Earnings release: Q4 2025

Mar 19, 2026, 9:00 AM EDT - 3 months ago

NeurAxis Annual report: Q4 2025

2026-03-19T11:25:31.000Z - 3 months ago

Neuraxis reports Q4 revenue $968K vs. $761K last year

Mar 19, 2026, 7:05 AM EDT - 3 months ago

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

Jan 30, 2026, 7:00 AM EST - 5 months ago

NeurAxis Slides: Corporate presentation

Jan 15, 2026, 9:30 AM EST - 6 months ago

NeurAxis Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

2026-01-08T13:38:18.000Z - 6 months ago

Neuraxis announces Category I CPT code for PENFS now in effect

2026-01-05T16:05:09.000Z - 6 months ago

Neuraxis management to meet virtually with Craig-Hallum

2025-12-22T15:25:50.000Z - 6 months ago

Neuraxis management to meet virtually with Craig-Hallum

2025-12-22T14:30:21.000Z - 6 months ago

Neuraxis price target raised to $8 from $7 at Craig-Hallum

2025-12-19T13:15:39.000Z - 7 months ago

Neuraxis achieves medical coverage policy milestone for PENFS

2025-12-01T12:20:49.000Z - 7 months ago

Neuraxis secures VA Federal Supply Schedule contract

2025-11-12T13:31:25.000Z - 8 months ago

Neuraxis announces new medical policy coverage in Michigan

Nov 11, 2025, 9:00 AM EST - 8 months ago

NeurAxis Earnings Call Transcript: Q3 2025

Nov 11, 2025, 9:00 AM EST - 8 months ago

NeurAxis Earnings release: Q3 2025

Nov 11, 2025, 9:00 AM EST - 8 months ago

NeurAxis Quarterly report: Q3 2025

2025-11-11T12:06:10.000Z - 8 months ago

Neuraxis reports Q3 revenue $811k vs $667k last year

Nov 11, 2025, 7:00 AM EST - 8 months ago

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

2025-10-24T12:11:28.000Z - 9 months ago

Neuraxis received FDA 510k clearance for PENFS technology

Sep 30, 2025, 11:00 AM EDT - 9 months ago

NeurAxis Transcript: Lytham Partners Fall 2025 Investor Conference

Aug 12, 2025, 9:00 AM EDT - 11 months ago

NeurAxis Earnings Call Transcript: Q2 2025

Aug 12, 2025, 9:00 AM EDT - 11 months ago

NeurAxis Earnings release: Q2 2025

Aug 12, 2025, 9:00 AM EDT - 11 months ago

NeurAxis Quarterly report: Q2 2025

Aug 12, 2025, 9:00 AM EDT - 11 months ago

NeurAxis Slides: Q2 2025

2025-08-12T11:06:07.000Z - 11 months ago

Neuraxis reports Q2 EPS (22c) vs. (42c) last year

2025-06-19T20:45:06.000Z - 1 year ago

Neuraxis management to meet with Craig-Hallum

2025-06-17T12:10:40.000Z - 1 year ago

Neuraxis announces new medical policy with two health insurers

Jun 17, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives

2025-06-16T13:15:09.000Z - 1 year ago

Craig-Hallum bullish on Neuraxis, initiates with a Buy

2025-06-16T11:30:07.000Z - 1 year ago

Neuraxis initiated with a Buy at Craig-Hallum

2025-06-10T12:30:42.000Z - 1 year ago

Neuraxis secures key academic society guidelines recommendation for FAP

May 29, 2025, 9:30 AM EDT - 1 year ago

NeurAxis Transcript: Lytham Partners Spring 2025 Investor Conference

2025-05-23T15:10:13.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

AKRO APVO CVM ETNB NLSP RLMD TIL

May 22, 2025, 1:03 PM EDT - 1 year ago

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

2025-05-22T14:41:04.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

ARMP NLSP NVAX PRME TIL TNGX

2025-05-21T11:15:19.000Z - 1 year ago

Neuraxis prices 1.54M shares at $3.25 in registered direct offering

May 21, 2025, 7:00 AM EDT - 1 year ago

NeurAxis Announces $5.0 Million Registered Direct Offering

May 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings Call Transcript: Q1 2025

May 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings release: Q1 2025

May 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Quarterly report: Q1 2025

May 12, 2025, 8:15 AM EDT - 1 year ago

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

May 5, 2025, 9:00 AM EDT - 1 year ago

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025

Apr 23, 2025, 5:00 PM EDT - 1 year ago

NeurAxis Transcript: Planet MicroCap Showcase: VEGAS 2025

Apr 14, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Proxy statement: Proxy Filing

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings Call Transcript: Q4 2024

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings release: Q4 2024

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Annual report: Q4 2024

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Slides: Q4 2024

Mar 20, 2025, 8:15 AM EDT - 1 year ago

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

Mar 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025

Feb 5, 2025, 7:00 AM EST - 1 year ago

NeurAxis Registration statement: Registration Filing

Jan 21, 2025, 1:45 PM EST - 1 year ago

UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States

Jan 21, 2025, 9:00 AM EST - 1 year ago

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

Jan 13, 2025, 2:30 PM EST - 1 year ago

NeurAxis Transcript: Lytham Partners 2025 Investor Healthcare Summit

Jan 13, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. Issues Letter to Shareholders

Jan 6, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Dec 13, 2024, 7:00 AM EST - 1 year ago

NeurAxis Registration statement: Registration Filing

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Earnings Call Transcript: Q3 2024

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Quarterly report: Q3 2024

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Earnings release: Q3 2024

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Slides: Q3 2024

Nov 12, 2024, 8:10 AM EST - 1 year ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Oct 22, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

Oct 1, 2024, 12:30 PM EDT - 1 year ago

NeurAxis Transcript: Lytham Partners Fall 2024 Investor Conference

Sep 19, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Aug 27, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

Aug 13, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

Aug 9, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings Call Transcript: Q2 2024

Aug 9, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Quarterly report: Q2 2024

Aug 9, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q2 2024

Aug 9, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Reports Second Quarter 2024 Financial Results

Jul 1, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Proxy statement: Proxy Filing

Jul 1, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Proxy statement: Proxy Filing

Jun 21, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Proxy statement: Proxy Filing

Jun 7, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

May 22, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings Call Transcript: Q1 2024

May 22, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Quarterly report: Q1 2024

May 22, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q1 2024

May 22, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Reports First Quarter 2024 Financial Results

May 21, 2024, 9:00 AM EDT - 2 years ago

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

Apr 23, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces New Medical Policy Coverage in North Dakota

Apr 9, 2024, 4:05 PM EDT - 2 years ago

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Apr 9, 2024, 7:00 AM EDT - 2 years ago

NeurAxis Annual report: Q4 2023

Apr 9, 2024, 7:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q4 2023

Apr 1, 2024, 4:15 PM EDT - 2 years ago

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry

Mar 11, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces Highmark BCBS Policy Coverage

Mar 4, 2024, 9:00 AM EST - 2 years ago

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

Feb 27, 2024, 11:00 AM EST - 2 years ago

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Jan 31, 2024, 9:00 AM EST - 2 years ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Dec 20, 2023, 9:00 AM EST - 2 years ago

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Nov 20, 2023, 5:30 PM EST - 2 years ago

NeurAxis Reports Third Quarter 2023 Financial Results

Nov 20, 2023, 8:00 AM EST - 2 years ago

NeurAxis Quarterly report: Q3 2023

Nov 20, 2023, 8:00 AM EST - 2 years ago

NeurAxis Earnings release: Q3 2023

Nov 15, 2023, 9:00 AM EST - 2 years ago

NeurAxis Announces CareFirst BCBS Policy Coverage

Nov 14, 2023, 9:00 AM EST - 2 years ago

NeurAxis Secures $3 Million Financing

Nov 8, 2023, 9:00 AM EST - 2 years ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Sep 21, 2023, 8:00 AM EDT - 3 years ago

NeurAxis Reports Second Quarter 2023 Financial Results

Sep 21, 2023, 8:00 AM EDT - 3 years ago

NeurAxis Quarterly report: Q2 2023

Sep 21, 2023, 8:00 AM EDT - 3 years ago

NeurAxis Earnings release: Q2 2023

Sep 13, 2023, 9:00 AM EDT - 3 years ago

NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

Aug 29, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Highlights Pediatric Post-Concussion Clinical Study

Aug 24, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Highlights Strength of its Board of Directors

Aug 22, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

Aug 17, 2023, 9:02 AM EDT - 3 years ago

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

Aug 15, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023

Aug 11, 2023, 9:30 AM EDT - 3 years ago

Goldman Small Cap Research Publishes New Research Report on NeurAxis, Inc.

Aug 9, 2023, 10:00 AM EDT - 3 years ago

NeurAxis Announces Pricing of Initial Public Offering

Finnish_boy Jun. 30 at 8:59 PM

$NRXS Someone wanted to double position size when there was chance to lock in lower levels.

1 · Reply

R33dh Jun. 30 at 6:20 PM

$NRXS it's a buy for me

0 · Reply

Finnish_boy Jun. 26 at 5:17 PM

$NRXS Commerical coverage win will happen likely August-October. I read more stuff today. So my earlier post June-July was misleading. But you never know. Q2 earnings report next catalyst in August.

1 · Reply

Finnish_boy Jun. 25 at 1:00 PM

1 · Reply

Finnish_boy Jun. 25 at 12:57 PM

$NRXS Major commercial coverage win very likely in July or August.

0 · Reply

Finnish_boy Jun. 25 at 8:13 AM

0 · Reply

Finnish_boy Jun. 9 at 4:11 PM

$NRXS Added $6.5, next buy $5.75-$6.25

0 · Reply

Finnish_boy Jun. 9 at 1:55 PM

$NRXS If stock drops to 5s, it wont be there long time bc that triggers multiple substack articles and twitter posts.

1 · Reply

Finnish_boy Jun. 9 at 1:21 PM

1 · Reply

CBAZZ03 Jun. 6 at 3:33 PM

3 · Reply

Finnish_boy Jun. 1 at 7:02 PM

$NRXS Forming potential bottom low 7s.

0 · Reply

Finnish_boy Jun. 1 at 3:44 PM

$NRXS We need Cunha

1 · Reply

SuperGreenToday May. 30 at 12:55 AM

$NRXS

0 · Reply

Finnish_boy May. 27 at 2:01 PM

$NRXS If someone wonders why stock is up.

0 · Reply

Finnish_boy May. 27 at 7:42 AM

$NRXS Sold all low 8s and 7.5s. I realized stock performance is all about Cunha's twitter posts and substrack. He became quiet so i sold. I bought first batch back at $7.1 .. no catalyst before potential coverage win late June/July. 1Y PT $15. By the end of year $10. Max pain is $6.4. Triggers multiple twitter posts and new deep dive. At $5.9 Microcapclub step in with new Ceo interview.

1 · Reply

cleverrox May. 22 at 2:57 PM

$NRXS https://microcapopportunities.substack.com/p/neuraxis-va-ramp

0 · Reply

stocktrader1549 May. 19 at 11:28 PM

$NRXS junk

0 · Reply

Finnish_boy May. 19 at 9:13 AM

$NRXS If no cunha posts, then i expect trading between 7 and 8 until the new coverage news that are out in late June.

0 · Reply

stocktrader1549 May. 18 at 1:59 PM

$NRXS junk

1 · Reply

Finnish_boy May. 17 at 11:01 AM

Multibaggers that i shouldnt have missed: RKLB and LQDA. Next multibaggers that i will not miss: $HROW $PYPD $NRXS I like also IREN, CIFR, HITI, and TMDX.

1 · Reply

Finnish_boy May. 15 at 11:49 AM

$NRXS https://mvcinvesting.substack.com/p/neuraxis-nrxs-q1-2026-earnings-review

0 · Reply

Finnish_boy May. 14 at 6:04 PM

$NRXS $MVC

0 · Reply

Market Cap	87.43M
Revenue (ttm)	3.57M
Net Income (ttm)	-7.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-218.49%
Debt to Equity Ratio	0.00

Volume	40,900
Avg Vol	152,338
Day's Range	N/A - N/A
Shares Out	12.38M
Stochastic %K	51%
Beta	1.43
Analysts	Strong Sell
Price Target	$13.00